当前位置:首页 - 行情中心 - 步长制药(603858) - 财务分析 - 现金流量表

步长制药

(603858)

  

流通市值:152.49亿  总市值:152.49亿
流通股本:10.55亿   总股本:10.55亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,179,183,019.32,431,477,425.4411,197,877,205.878,100,939,408.2
  收到的税费返还1,942,002.36163,994.4135,400.57-
  收到其他与经营活动有关的现金71,848,852.5328,728,739.4557,034,784.06177,641,989.97
  经营活动现金流入小计5,252,973,874.192,460,370,159.311,254,947,390.58,278,581,398.17
  购买商品、接受劳务支付的现金1,723,612,328.58822,743,873.253,003,227,701.432,063,410,259.46
  支付给职工以及为职工支付的现金459,177,246.94237,528,806.34956,051,118.68747,045,197.46
  支付的各项税费754,061,076.6415,025,262.921,276,824,161.72955,721,908
  支付其他与经营活动有关的现金2,018,490,351.551,020,519,485.474,861,057,333.823,697,312,120.54
  经营活动现金流出小计4,955,341,003.672,495,817,427.9810,097,160,315.657,463,489,485.46
  经营活动产生的现金流量净额297,632,870.52-35,447,268.681,157,787,074.85815,091,912.71
二、投资活动产生的现金流量:
  收回投资收到的现金6,8756,87599,036,147.258,800,000
  取得投资收益收到的现金108,774,294.79107,166,582.287,239,731.575,414,940.38
  处置固定资产、无形资产和其他长期资产收回的现金净额319,296.78167,346.8214,262.2211,710
  收到的其他与投资活动有关的现金1,617,112.09785,642.674,902,108.814,236,249.91
  投资活动现金流入小计110,717,578.66108,126,446.75111,392,249.8318,662,900.29
  购建固定资产、无形资产和其他长期资产支付的现金87,026,275.7316,603,343.12123,424,399.4185,697,216.54
  投资支付的现金114,985,190.13240,940,48030,000,000286,924,270
  支付其他与投资活动有关的现金37,226.15218,002.72--
  投资活动现金流出小计202,048,692.01257,761,825.84153,424,399.41372,621,486.54
  投资活动产生的现金流量净额-91,331,113.35-149,635,379.09-42,032,149.58-353,958,586.25
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,205,172736,84019,920,0003,062,500
  其中:子公司吸收少数股东投资收到的现金1,205,172736,84019,920,0003,062,500
  取得借款收到的现金2,058,639,841.141,388,219,841.141,847,668,5791,418,800,079
  收到其他与筹资活动有关的现金542,200.31502,657.92101,258,978.2481,254,122.92
  筹资活动现金流入小计2,060,387,213.451,389,459,339.061,968,847,557.241,503,116,701.92
  偿还债务支付的现金1,543,426,952.1610,342,072.11,961,053,044.11,254,504,826.54
  分配股利、利润或偿付利息支付的现金78,519,865.9850,410,514.07546,247,131.43512,913,054.68
  其中:子公司支付给少数股东的股利、利润24,716,627.623,816,627.615,538,427.7715,538,427.77
  支付其他与筹资活动有关的现金319,176,331.25159,230,901.5189,709,737.18148,123,308.03
  筹资活动现金流出小计1,941,123,149.33819,983,487.672,697,009,912.711,915,541,189.25
  筹资活动产生的现金流量净额119,264,064.12569,475,851.39-728,162,355.47-412,424,487.33
四、汇率变动对现金及现金等价物的影响-12,695.62-81,778.15-75,142.76-8,302.28
五、现金及现金等价物净增加额325,553,125.67384,311,425.47387,517,427.0448,700,536.85
  加:期初现金及现金等价物余额1,205,050,400.81,205,284,719.28817,532,973.76817,532,973.76
  期末现金及现金等价物余额1,530,603,526.471,589,596,144.751,205,050,400.8866,233,510.61
补充资料:
  净利润461,825,547.8-192,297,553.48-
  资产减值准备4,821,480.06-527,219,503.79-
  固定资产和投资性房地产折旧202,080,038.07-426,785,324.47-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧202,080,038.07-426,785,324.47-
  无形资产摊销39,679,900.02-75,440,863.37-
  长期待摊费用摊销12,658,638.14-7,301,389.01-
  处置固定资产、无形资产和其他长期资产的损失-109,725.39--156,484.37-
  固定资产报废损失433,244.04-745,945.05-
  公允价值变动损失21,862,922.75-279,493,363.52-
  财务费用56,844,868.08-113,863,697.97-
  投资损失24,748,867.49-3,840,753.16-
  递延所得税-7,217,458.45-33,649,814.19-
  其中:递延所得税资产减少-7,477,109.92-42,256,340.1-
    递延所得税负债增加259,651.47--8,606,525.91-
  存货的减少-163,915,725.17--42,804,237.71-
  经营性应收项目的减少436,022,258.33--684,542,618.54-
  经营性应付项目的增加-798,530,439.46-226,921,942.02-
  现金的期末余额1,530,603,526.47-1,205,050,400.8-
  减:现金的期初余额1,205,050,400.8-817,532,973.76-
  现金及现金等价物的净增加额325,553,125.67-387,517,427.04-
公告日期2026-08-282026-04-282026-04-282025-10-30
审计意见(境内)标准无保留意见
TOP↑